Literature DB >> 7508995

Influenza virus NS1 protein stimulates translation of the M1 protein.

K Enami1, T A Sato, S Nakada, M Enami.   

Abstract

The influenza virus NS1 protein was shown to stimulate translation of the M1 protein. M-CAT RNA, which contains the chloramphenicol acetyltransferase (CAT) reporter gene and the terminal noncoding sequence of segment 7 (coding for the M1 and M2 proteins), was ribonucleoprotein transfected into clone 76 cells expressing the influenza virus RNA polymerase and NP proteins required for the transcription and replication of influenza virus ribonucleoproteins. When the cells were superinfected with a recombinant vaccinia virus which expresses the NS1 protein, CAT expression from the M-CAT RNA was significantly stimulated but transcription was not altered. The expression of NS-CAT RNA, which contains noncoding sequences of segment 8 (coding for the NS1 and NS2 proteins), was not altered by the NS1 protein. Site-directed mutagenesis showed that the sequence GGUAGAUA upstream of the initiation codon on segment 7 was required for stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508995      PMCID: PMC236597     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Determination of influenza virus proteins required for genome replication.

Authors:  T S Huang; P Palese; M Krystal
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA.

Authors:  K Yamanaka; N Ogasawara; H Yoshikawa; A Ishihama; K Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import.

Authors:  K Martin; A Helenius
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

Review 4.  Translational control in mammalian cells.

Authors:  J W Hershey
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

5.  A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo.

Authors:  B L Seong; G G Brownlee
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

6.  Analysis of influenza A virus temperature-sensitive mutants with mutations in RNA segment 8.

Authors:  E Hatada; M Hasegawa; K Shimizu; M Hatanaka; R Fukuda
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

7.  Amplification, expression, and packaging of foreign gene by influenza virus.

Authors:  W Luytjes; M Krystal; M Enami; J D Parvin; P Palese
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  High-efficiency formation of influenza virus transfectants.

Authors:  M Enami; P Palese
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

9.  Promoter analysis of influenza virus RNA polymerase.

Authors:  J D Parvin; P Palese; A Honda; A Ishihama; M Krystal
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Temporal control for translation of influenza virus mRNAs.

Authors:  K Yamanaka; K Nagata; A Ishihama
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more
  54 in total

Review 1.  Translational control of viral gene expression in eukaryotes.

Authors:  M Gale; S L Tan; M G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

2.  A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum.

Authors:  R M Marión; P Fortes; A Beloso; C Dotti; J Ortín
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

3.  Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.

Authors:  J Talon; C M Horvath; R Polley; C F Basler; T Muster; P Palese; A García-Sastre
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Protein synthesis shut-off induced by influenza virus infection is independent of PKR activity.

Authors:  T Zürcher; R M Marión; J Ortín
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Glycine 184 in nonstructural protein NS1 determines the virulence of influenza A virus strain PR8 without affecting the host interferon response.

Authors:  Sabine Steidle; Luis Martínez-Sobrido; Markus Mordstein; Stefan Lienenklaus; Adolfo García-Sastre; Peter Stäheli; Georg Kochs
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

6.  Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus.

Authors:  T Aragón; S de la Luna; I Novoa; L Carrasco; J Ortín; A Nieto
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors.

Authors:  Stephan Ludwig; Xiuyan Wang; Christina Ehrhardt; Hongyong Zheng; Nicola Donelan; Oliver Planz; Stephan Pleschka; Adolfo García-Sastre; Gudrun Heins; Thorsten Wolff
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Human Staufen1 protein interacts with influenza virus ribonucleoproteins and is required for efficient virus multiplication.

Authors:  Susana de Lucas; Joan Peredo; Rosa María Marión; Carmen Sánchez; Juan Ortín
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

10.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.